DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A. et al.
Updated analysis of KEYNOTE-024: Pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer With PD-L1 tumor proportion score of 50% or greater.

J Clin Oncol 2019;
37: 537-46

Download Bibliographical Data

Access:
Access: